Dr. Urartu Özgür Safak Şeker and his graduate students Nazlıcan Tunç, Damla Albayrak, Senem Şen, Recep Erdem Ahan, Ahet Hınçer, Aslı Semirci, Ece Avcı, Melis Karaca, Merve Yavuz, Doğuş Akboğa, Mehmet Emin Bakar, Gozeel Shadid have published a new book titled “Synthetic Biology for Therapeutics: Engineering Cells for Living Drugs.” The book focuses on how synthetic biology can be applied to the development of new cancer therapies, particularly through the use of engineered genetic circuits within cells.
Dr. Şeker’s work explores the potential of cellular therapies, including microbial therapies and CAR-T cell therapies, as alternatives to traditional cancer treatments. It covers the engineering of mammalian and microbial cells to deliver targeted therapies as well as the development of biological devices for precise cellular targeting.
The book is intended for scientists and researchers in biotechnology, medicine and synthetic biology, providing insights into how the genetic engineering of cells can be used to create living drugs for the treatment of cancer and other diseases.
